CPSF6 Antibodies
We offer CPSF6 Antibodies for use in common research applications: ELISA, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunoprecipitation, Sandwich ELISA, Simple Western, Western Blot. Each CPSF6 Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our CPSF6 Antibodies can be used in a variety of model species: Human, Mouse, Rat. Use the list below to choose the CPSF6 Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our CPSF6 polyclonal antibodies and browse our CPSF6 monoclonal antibody catalog.
Alternate Names for CPSF6 Antibodies
anti-CPSF6 antibody, anti-CFIM antibody, anti-CFIm68 antibody, anti-CFIM68CPSF 68 kDa subunit antibody, anti-CFIMcleavage and polyadenylation specific factor 6, 68kD subunit antibody, anti-cleavage and polyadenylation specific factor 6, 68kDa antibody, anti-Cleavage and polyadenylation specificity factor 68 kDa subunit antibody, anti-cleavage and polyadenylation specificity factor subunit 6 antibody, anti-HPBRII-4 antibody, anti-HPBRII-7 antibody, anti-pre-mRNA cleavage factor I, 68kD subunit antibody, anti-pre-mRNA cleavage factor Im (68kD) antibody, anti-Pre-mRNA cleavage factor Im 68 kDa subunit antibody, anti-Protein HPBRII-4/7 antibody
9 Results for "cpsf6" in Primary Antibodies
![Immunocytochemistry/Immunofluorescence: CPSF6 Antibody [NBP1-85676] - Staining of human cell line A-431 shows localization to nucleoplasm & nuclear speckles. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-85676-img0010.jpg)
![Immunohistochemistry-Paraffin: CPSF6 Antibody [NBP1-85676] - Staining of human lymph node shows strong nuclear positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunohistochemistry-Paraffin-NBP1-85676-img0012.jpg)
![Western Blot: CPSF6 Antibody [NBP1-85676] - CPSF6-358 inhibits HIV-1 replication when localized to the cytoplasm. (A) CPSF6 protein in TZM-bl cells transduced with empty, CPSF6-358, CPSF6-358 NLS & CPSF6-358 NES vectors. Cell lysates were probed in western blots with anti-CPSF6 antibody (upper panel) & anti-beta -actin antibody (lower panel). The upper panel shows the endogenous CPSF6 & the truncated form. (B) Indirect immunofluorescence showing localization of the different forms of CPSF6-358. The TZM-bl cells, transduced as in (A), were stained with an anti-HA antibody (green) for the detection of the CPSF6-358 proteins. DAPI was used to mark the nuclear compartment (blue). (C) TZM-bl stably expressing the different forms of CPSF6-358 were challenged with WT or CA mutant HIV-1NL4-3GFP reporter viruses. After 72 hrs, GFP reporter expression was assessed by flow cytometry. Data represent one of at least three independent experiments. Error bars represent ± SEM (n = 3). Image collected & cropped by CiteAb from the following publication (//retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-20), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-85676_rabbit-polyclonal-cpsf6-antibody-31020241612239.jpg)
![Western Blot: CPSF6 Antibody [NBP1-85676] - HIV-1 replication is inhibited when full-length CPSF6 is targeted to the cytoplasm. (A) Expression levels of CPSF6 in TZM-bl cells transduced with empty, CPSF6, CPSF6-NLS & CPSF6-NES vectors. Cell lysates were probed in western blots with anti-CPSF6 antibody (upper panel) & anti-beta -actin antibody (lower panel). The upper panel shows the endogenous & exogenous full-length CPSF6 with an HA tag. (B) Localization of different forms of CPSF6 in TZM-bl cells stably expressing CPSF6, CPSF6 NLS or CPSF6 NES. The cells were stained with an anti-HA antibody (green) for the detection of the CPSF6 proteins. DAPI staining (blue) was used to mark the nuclear compartment. (C) TZM-bl stably expressing the different forms of CPSF6 were challenged with WT or CA mutant HIV-1NL4-3GFP reporter viruses. After 72 hours, GFP reporter expression was assessed by flow cytometry. Data represent one of at least three independent experiments. Error bars represent ± SEM (n = 3). Image collected & cropped by CiteAb from the following publication (//retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-20), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-85676_rabbit-polyclonal-cpsf6-antibody-3102024161221.jpg)
![Western Blot: CPSF6 Antibody [NBP1-85676] - HIV-1 replication is inhibited when full-length CPSF6 is targeted to the cytoplasm. (A) Expression levels of CPSF6 in TZM-bl cells transduced with empty, CPSF6, CPSF6-NLS & CPSF6-NES vectors. Cell lysates were probed in western blots with anti-CPSF6 antibody (upper panel) & anti-beta -actin antibody (lower panel). The upper panel shows the endogenous & exogenous full-length CPSF6 with an HA tag. (B) Localization of different forms of CPSF6 in TZM-bl cells stably expressing CPSF6, CPSF6 NLS or CPSF6 NES. The cells were stained with an anti-HA antibody (green) for the detection of the CPSF6 proteins. DAPI staining (blue) was used to mark the nuclear compartment. (C) TZM-bl stably expressing the different forms of CPSF6 were challenged with WT or CA mutant HIV-1NL4-3GFP reporter viruses. After 72 hours, GFP reporter expression was assessed by flow cytometry. Data represent one of at least three independent experiments. Error bars represent ± SEM (n = 3). Image collected & cropped by CiteAb from the following publication (//retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-20), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-85676_rabbit-polyclonal-cpsf6-antibody-31020241612232.jpg)
![Western Blot: CPSF6 Antibody [NBP1-85676] - The effect of CPSF6-358 on the infectivity of HIV-1 CA mutants correlates with the effect of TNPO3 KD. (A) Schematic representation of the protein domains of WT CPSF6 & the truncated mutant CPSF6-358. RNA recognition motif (RRM), proline-rich domain (P-rich), arginine/serine rich domain (RS). (B) Expression levels of CPSF6 in TZM-bl cells transduced with empty or CPSF6-358 vectors. Cell lysates were probed in western blots with anti-CPSF6 antibody (upper panel) & anti-beta -actin antibody (lower panel). The upper panel shows the endogenous CPSF6 & the truncated form. (C) TZM-bl cells transduced with an empty vector or with a vector encoding CPSF6-358 were challenged with a panel of 27 HIV-1-GFP reporter vectors bearing either WT CA or the indicated CA mutants. At 72 hrs the percent GFP+ cells was determined by flow cytometry as an indication of infectivity. The ratio of HIV-1 infectivity in CPSF6-358 expressing cells & empty vector cells is shown. White bars show CA mutants inhibited to a similar extent as the WT virus by CPSF6-358, black bars shows CA mutants insensitive or slightly sensitive to CPSF6-358, & gray bars show CA mutants hypersensitive to the presence of CPSF6-358 in the cell. (D) Correlation between the infectivity ratios of the 27 CA mutants when infecting Ctrl KD vs TNPO3 KD [8] & Empty vector vs CPSF6-358 (R2 = 0.8528). Image collected & cropped by CiteAb from the following publication (//retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-20), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-85676_rabbit-polyclonal-cpsf6-antibody-310202416121945.jpg)
![Western Blot: CPSF6 Antibody [NBP1-85676] - TNPO3 depletion does not inhibit HIV-1 if CPSF6 is independently targeted to the nucleus. (A) CPSF6 & TNPO3 protein in TZM-bl cells stably transduced with CPSF6 KD vectors, control or TNPO3 KD vectors, & rescue of CPSF6 (ntCPSF6) with or without the SV40 T-Ag NLS. Cell lysate was probed in western blots with anti-TNPO3 antibody (upper panel), anti-CPSF6 antibody (middle panel) & anti-beta -actin antibody (lower panel). (B) Localization of the non-targetable CPSF6 (ntCPSF6) constructs (green) in control (Ctrl) KD or TNPO3 KD TZM-bl cells stably depleted of CPSF6. DAPI staining (blue) was used to mark the nuclear compartment. (C) The pools of stable cell lines in (B) were challenged with WT or CA mutant HIV-1NL4-3GFP reporter viruses. After 72 hrs, GFP expression was checked by flow cytometry. Data represent one of at least three independent experiments. Error bars represent ± SEM (n = 3). Image collected & cropped by CiteAb from the following publication (//retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-20), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-85676_rabbit-polyclonal-cpsf6-antibody-31020241613648.jpg)
![Immunocytochemistry/ Immunofluorescence: CPSF6 Antibody [NBP1-85676] - TNPO3 depletion does not inhibit HIV-1 if CPSF6 is independently targeted to the nucleus. (A) CPSF6 & TNPO3 protein in TZM-bl cells stably transduced with CPSF6 KD vectors, control or TNPO3 KD vectors, & rescue of CPSF6 (ntCPSF6) with or without the SV40 T-Ag NLS. Cell lysate was probed in western blots with anti-TNPO3 antibody (upper panel), anti-CPSF6 antibody (middle panel) & anti-beta -actin antibody (lower panel). (B) Localization of the non-targetable CPSF6 (ntCPSF6) constructs (green) in control (Ctrl) KD or TNPO3 KD TZM-bl cells stably depleted of CPSF6. DAPI staining (blue) was used to mark the nuclear compartment. (C) The pools of stable cell lines in (B) were challenged with WT or CA mutant HIV-1NL4-3GFP reporter viruses. After 72 hrs, GFP expression was checked by flow cytometry. Data represent one of at least three independent experiments. Error bars represent ± SEM (n = 3). Image collected & cropped by CiteAb from the following publication (//retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-20), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-85676_rabbit-polyclonal-cpsf6-antibody-310202416121927.jpg)
![Western Blot: CPSF6 Antibody [NB100-61596] - Whole cell lysate (15 ug) from HeLa, 293T, Jurkat, mouse TCMK-1, and mouse NIH3T3 cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit antiCPSF68 antibody used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.](http://images.novusbio.com/fullsize/CPSF6-Antibody-Western-Blot-NB100-61596-img0006.jpg "Western Blot: CPSF6 Antibody [NB100-61596] - Whole cell lysate (15 ug) from HeLa, 293T, Jurkat, mouse TCMK-1, and mouse NIH3T3 cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit antiCPSF68 antibody used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.")
![Immunocytochemistry/Immunofluorescence: CPSF6 Antibody [NB100-61596] - TNPO3 K.D. and shRNA control HeLa cells were transiently transfected using constructs expressing FLAG-tagged CPSF6. Twenty-four hours post-transfection cells were fixed and immunostained using anti-FLAG antibodies. The nuclear compartment was labeled using DAPI.Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/23622145/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunocytochemistry-Immunofluorescence-NB100-61596-img0008.jpg)
![Immunohistochemistry-Paraffin: CPSF6 Antibody [NB100-61596] - FFPE section of mouse renal cell carcinoma. Antibody: Affinity purified rabbit anti-CPSF68 used at a dilution of 1:200 (1ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunohistochemistry-Paraffin-NB100-61596-img0005.jpg)
![Immunohistochemistry-Paraffin: CPSF6 Antibody [NB100-61596] - FFPE section of human colon carcinoma. Antibody: Affinity purified rabbit anti-CPSF68 used at a dilution of 1:200 (1ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunohistochemistry-Paraffin-NB100-61596-img0004.jpg)
![Simple Western: CPSF6 Antibody [NB100-61596] - Simple Western lane view shows a specific band for CPSF6 in 0.5 mg/ml of HeLa lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.](http://images.novusbio.com/fullsize/CPSF6-Antibody-Simple-Western-NB100-61596-img0003.jpg)
![<b>Independent Antibodies Validation. </b>Immunoprecipitation: CPSF6 Antibody [NB100-61596] - Detection of human CPSF68 by western blot of immunoprecipitates. Samples: Whole cell lysate (1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-CPSF68 antibody NB100-61596 (lot NB100-61596-2) used for IP at 3 ug per reaction. CPSF68 was also immunoprecipitated by a previous lot of this antibody (lot NB100-61596-1) and another rabbit anti-CPSF68 antibody. For blotting immunoprecipitated CPSF68, NB100-61596 was used at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunoprecipitation-NB100-61596-img0007.jpg)
![Immunocytochemistry/ Immunofluorescence: CPSF6 Antibody [NB100-61596] - Depletion of TNPO3 does not change the localization of CPSF6. (A) TNPO3 K.D. & shRNA control HeLa cells were fixed & stained using specific antibodies against CPSF6 (red), ASF/SF2 (red) & TNPO3 (green), as described in Methods. The nuclear compartment was labeled using DAPI. Image quantification is shown in Additional file 1. (B) TNPO3 K.D. & shRNA control HeLa cells were transiently transfected using constructs expressing FLAG-tagged CPSF6 or ASF/SF2. Twenty-four hours post-transfection cells were fixed & immunostained using anti-FLAG antibodies. The nuclear compartment was labeled using DAPI. Image quantification is shown in Additional file 2. Similar results were obtained in three independent experiments & a representative experiment is shown. Image collected & cropped by CiteAb from the following publication (//retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-46), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-61596_rabbit-polyclonal-cpsf6-antibody-31020241554199.jpg)
![Western Blot: CPSF6 Antibody (3F11) [H00011052-M10] - Analysis of CPSF6 expression in Raw 264.7 (Cat # L024V1).](http://images.novusbio.com/fullsize/CPSF6-Antibody-3F11-Western-Blot-H00011052-M10-img0010.jpg "Western Blot: CPSF6 Antibody (3F11) [H00011052-M10] - Analysis of CPSF6 expression in Raw 264.7 (Cat # L024V1).")
![Immunocytochemistry/Immunofluorescence: CPSF6 Antibody (3F11) [H00011052-M10] - Analysis of monoclonal antibody to CPSF6 on HeLa cell. Antibody concentration 10 ug/ml](http://images.novusbio.com/fullsize/CPSF6-Antibody-3F11-Immunocytochemistry-Immunofluorescence-H00011052-M10-img0007.jpg)
![Western Blot: CPSF6 Antibody (3F11) [H00011052-M10] - Analysis of CPSF6 expression in HeLa (Cat # L013V1).](http://images.novusbio.com/fullsize/CPSF6-Antibody-3F11-Western-Blot-H00011052-M10-img0008.jpg)
![Western Blot: CPSF6 Antibody (3F11) [H00011052-M10] - Analysis of CPSF6 expression in HL-60 (Cat # L014V1).](http://images.novusbio.com/fullsize/CPSF6-Antibody-3F11-Western-Blot-H00011052-M10-img0009.jpg)
![Western Blot: CPSF6 Antibody (3F11) [H00011052-M10] - Analysis of CPSF6 expression in transfected 293T cell line by CPSF6 monoclonal antibody (M10), clone 3F11. Lane 1: CPSF6 transfected lysatE (59.21 KDa). Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/CPSF6-Antibody-3F11-Western-Blot-H00011052-M10-img0011.jpg)
![ELISA: CPSF6 Antibody (3F11) [H00011052-M10] - Detection limit for recombinant GST tagged CPSF6 is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/CPSF6-Antibody-3F11-ELISA-H00011052-M10-img0006.jpg)
![Immunoprecipitation: CPSF6 Antibody [NBP3-38219] - Immunoprecipitation analysis of 300 ug extracts of 293T cells using 3 ug CPSF6 antibody. Western blot was performed from the immunoprecipitate using CPSF6 antibody at a dilution of 1:1000.](http://images.novusbio.com/fullsize/nbp3-38219_rabbit-cpsf6-pab-91220241519551.jpg "Immunoprecipitation: CPSF6 Antibody [NBP3-38219] - Immunoprecipitation analysis of 300 ug extracts of 293T cells using 3 ug CPSF6 antibody. Western blot was performed from the immunoprecipitate using CPSF6 antibody at a dilution of 1:1000.")
![Immunocytochemistry/ Immunofluorescence: CPSF6 Antibody [NBP3-38219] - Confocal immunofluorescence analysis of U2OS cells using CPSF6 Rabbit pAb at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/nbp3-38219_rabbit-cpsf6-pab-912202414123881.jpg)
![Western Blot: CPSF6 Antibody [NBP3-38219] - Western blot analysis of various lysates using CPSF6 Rabbit pAb at 1:1000 dilution.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 1s.](http://images.novusbio.com/fullsize/nbp3-38219_rabbit-cpsf6-pab-91220241513347.jpg)
![Immunohistochemistry: CPSF6 Antibody [NBP3-38219] - Immunohistochemistry analysis of paraffin-embedded Rat testis using CPSF6 Rabbit pAb at dilution of 1:100 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-38219_rabbit-cpsf6-pab-912202414112867.jpg)
![Immunohistochemistry: CPSF6 Antibody [NBP3-38219] - Immunohistochemistry analysis of paraffin-embedded Mouse lung using CPSF6 Rabbit pAb at dilution of 1:100 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-38219_rabbit-cpsf6-pab-9122024159571.jpg)
![Immunohistochemistry: CPSF6 Antibody [NBP3-38219] - Immunohistochemistry analysis of paraffin-embedded Human esophageal cancer using CPSF6 Rabbit pAb at dilution of 1:100 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-38219_rabbit-cpsf6-pab-912202414163014.jpg)
![Immunohistochemistry: CPSF6 Antibody [NBP3-38219] - Immunohistochemistry analysis of paraffin-embedded Human thyroid cancer using CPSF6 Rabbit pAb at dilution of 1:100 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-38219_rabbit-cpsf6-pab-9122024158121.jpg)
![Western Blot: CPSF6 Antibody [NBP2-99189] - Anti-CPSF6 rabbit polyclonal antibody at 1:500 dilution. Lane A: Jurkat Whole Cell Lysate. Lane B: K562 Whole Cell Lysate. Lane C: A431 Whole Cell Lysate. Lane D: HepG2 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti- Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 59 kDa. Observed band size: 72 kDa (We are unsure as to the identity of these extra bands).](http://images.novusbio.com/fullsize/CPSF6-Antibody-Western-Blot-NBP2-99189-img0003.jpg "Western Blot: CPSF6 Antibody [NBP2-99189] - Anti-CPSF6 rabbit polyclonal antibody at 1:500 dilution. Lane A: Jurkat Whole Cell Lysate. Lane B: K562 Whole Cell Lysate. Lane C: A431 Whole Cell Lysate. Lane D: HepG2 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti- Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 59 kDa. Observed band size: 72 kDa (We are unsure as to the identity of these extra bands).")
![Immunocytochemistry/Immunofluorescence: CPSF6 Antibody [NBP2-99189] - Immunofluorescence staining of CPSF6 in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with rabbit anti-human CPSF6 polyclonal antibody (1:1000) at 4C overnight. Then cells were stained with the Alexa Fluor(R)488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to nucleus.](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-99189-img0002.jpg)
![Immunohistochemistry-Paraffin: CPSF6 Antibody [NBP2-99189] - Immunochemical staining of human CPSF6 in human colon carcinoma with rabbit polyclonal antibody (1:1000, formalin-fixed paraffin embedded sections).](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunohistochemistry-Paraffin-NBP2-99189-img0005.jpg)
![Immunohistochemistry-Paraffin: CPSF6 Antibody [NBP2-99189] - Immunochemical staining of human CPSF6 in human breast carcinoma with rabbit polyclonal antibody (1:1000, formalin-fixed paraffin embedded sections).](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunohistochemistry-Paraffin-NBP2-99189-img0004.jpg)
![Immunoprecipitation: CPSF6 Antibody [NBP2-99189] - CPSF6 was immunoprecipitated using: Lane A: 0.5 mg Hela Whole Cell Lysate. Lane B: 0.5 mg K562 Whole Cell Lysate. Lane C: 0.5 mg Jurkat Whole Cell Lysate4 ul anti-CPSF6 rabbit polyclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-CPSF6 rabbit polyclonal antibody, at 1:100 dilution. Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 60 kDa. Observed band size: 72 kDa](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunoprecipitation-NBP2-99189-img0001.jpg)
![Western Blot: CPSF6 Antibody [NBP1-57541] - Jurkat cell lysate, Antibody Titration: 0.3125ug/ml](http://images.novusbio.com/fullsize/CPSF6-Antibody-Western-Blot-NBP1-57541-img0001.jpg "Western Blot: CPSF6 Antibody [NBP1-57541] - Jurkat cell lysate, Antibody Titration: 0.3125ug/ml")
![Immunocytochemistry/Immunofluorescence: CPSF6 Antibody [NBP1-57541] - SKOV3 Primary Antibody Dilution: 4 ug/ml Secondary Antibody : Anti-rabbit Alexa 546 Secondary Antibody Dilution: 2 ug/ml](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-57541-img0004.jpg)
![Immunohistochemistry-Paraffin: CPSF6 Antibody [NBP1-57541] - Human Muscle Tissue, Skeletal muscle cells (Indicated with Arrows) 4-8ug/ml.](http://images.novusbio.com/fullsize/CPSF6-Antibody-Immunohistochemistry-Paraffin-NBP1-57541-img0003.jpg)
![Western Blot: CPSF6 Antibody (1C5) [H00011052-M07] - Analysis of CPSF6 expression in NIH/3T3 (Cat # L018V1).](http://images.novusbio.com/fullsize/CPSF6-Antibody-1C5-Western-Blot-H00011052-M07-img0004.jpg "Western Blot: CPSF6 Antibody (1C5) [H00011052-M07] - Analysis of CPSF6 expression in NIH/3T3 (Cat # L018V1).")
![Immunocytochemistry/Immunofluorescence: CPSF6 Antibody (1C5) [H00011052-M07] - Analysis of monoclonal antibody to CPSF6 on HeLa cell. Antibody concentration 10 ug/ml](http://images.novusbio.com/fullsize/CPSF6-Antibody-1C5-Immunocytochemistry-Immunofluorescence-H00011052-M07-img0002.jpg)
![Sandwich ELISA: CPSF6 Antibody (1C5) [H00011052-M07] - Detection limit for recombinant GST tagged CPSF6 is 0.3 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/CPSF6-Antibody-1C5-Sandwich-ELISA-H00011052-M07-img0003.jpg)